secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001493152-23-040008
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis Q3 revenue $7.8M (+1% YoY); net loss $5.4M; cash $23M, no debt
--------------------------------------------------------------------------

- System revenue $3.5M from 2 Genesis systems; recurring revenue $4.3M (down 19% YoY, lost catheter royalties).
- Gross margin 52%; operating loss $5.6M vs $5.1M a year ago; adjusted operating loss $3.0M.
- Cash and equivalents $23.0M at Sept 30, 2023; no debt; negative free cash flow $1.0M in Q3.
- Expects to submit PMA supplement for MAGiC ablation catheter before year-end.
- System backlog $13M; expects continued revenue growth in coming quarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315223040008/0001493152-23-040008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315223040008/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-040008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer